Tor Audun Hervig's picture

Tor Audun Hervig

  • E-mailtor.hervig@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Training of medical students in the use of emergency whole blood collection and transfusion in the framework of a civilian walking blood. Transfusion. S60-S66.
  • Show author(s) (2023). Evidensbasert transfusjonspraksis ved jernmangelanemi. Tidsskrift for Den norske legeforening.
  • Show author(s) (2023). Covid-19-pasienter behandlet med rekonvalesensplasma. Tidsskrift for Den norske legeforening.
  • Show author(s) (2023). Convalescent plasma from Norwegian blood donors to treat COVID-19. Tidsskrift for Den norske legeforening.
  • Show author(s) (2022). In vitro quality and hemostatic function of cold-stored CPDA-1 whole blood after repeated transient exposure to 28°C storage temperature. Transfusion. S105-S113.
  • Show author(s) (2022). Carbamylation of integrin αIIbβ3: The mechanistic link to platelet dysfunction in ESKD. Journal of the American Society of Nephrology. 1841-1856.
  • Show author(s) (2021). Spontaneous Splenic Artery Rupture as the First Symptom of Systemic Amyloidosis. Case Reports in Critical Care.
  • Show author(s) (2021). Prehospital Whole Blood Transfusion Programs in Norway. Transfusion Medicine and Hemotherapy. 324-330.
  • Show author(s) (2021). Platelet microparticles protect acute myelogenous leukemia cells against daunorubicin-induced apoptosis. Cancers. 1-17.
  • Show author(s) (2021). Platelet microparticles decrease daunorubicin‐induced dna damage and modulate intrinsic apoptosis in thp‐1 cells. International Journal of Molecular Sciences. 1-16.
  • Show author(s) (2021). Pasientar og blodgivarar med hemokromatose:ei spørjeundersøking ved Helse Førde. Bioingeniøren. 28-32.
  • Show author(s) (2021). In vitro characteristics and in vivo platelet quality of whole blood treated with riboflavin and UVA/UVB light and stored for 24 hours at room temperature. Transfusion. S101-S110.
  • Show author(s) (2021). Freeze-dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies. American Journal of Hematology.
  • Show author(s) (2021). Effect of leukoreduction and temperature on risk of bacterial growth in CPDA-1 whole blood: A study of Escherichia coli. Transfusion. S80-S89.
  • Show author(s) (2021). A whole blood based resuscitation strategy in civilian medical services: Experience from a Norwegian hospital in the period 2017–2020. Transfusion. S22-S31.
  • Show author(s) (2020). Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering. Stem Cell Research & Therapy. 1-18.
  • Show author(s) (2020). Environmental pollutants in blood donors: The multicentre Norwegian donor study. Transfusion Medicine. 1-9.
  • Show author(s) (2020). Cold-stored whole blood in a Norwegian emergency helicopter service: an observational study on storage conditions and product quality. Transfusion. 1544-1551.
  • Show author(s) (2020). Cold-stored leukoreduced CPDA-1 whole blood: in vitro quality and hemostatic properties. Transfusion. 1042-1049.
  • Show author(s) (2020). A pilot trial of platelets stored cold versus at room temperature for complex cardiothoracic surgery. Anesthesiology. 1173-1183.
  • Show author(s) (2019). Multiple electrode aggregometry and thromboelastography in thrombocytopenic patients with haematological malignancies. Blood Transfusion. 181-190.
  • Show author(s) (2019). In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days. Transfusion. 2652-2661.
  • Show author(s) (2019). How do I get an emergency civilian walking blood bank running? Transfusion. 1446-1452.
  • Show author(s) (2018). The healthy donor profile of immunoregulatory soluble mediators is altered by stem cell mobilization and apheresis. Cytotherapy. 740-754.
  • Show author(s) (2018). RBC alloantibody prevalence and specificity in a Western Norwegian tertiary hospital. Transfusion Medicine. 1-10.
  • Show author(s) (2018). Preparation of leukoreduced whole blood for transfusion in austere environments; effects of forced filtration, storage agitation, and high temperatures on hemostatic function. Journal of Trauma and Acute Care Surgery. S93-S103.
  • Show author(s) (2018). Massive transfusion: changing practice in a single Norwegian centre 2002?2015. Transfusion Medicine. 357-362.
  • Show author(s) (2018). Immediate effects of blood donation on physical and cognitive performance-A randomized controlled double-blinded trial. Journal of Trauma and Acute Care Surgery. S125-S131.
  • Show author(s) (2018). Hemostatic efficacy of pathogen-inactivated vs untreated platelets: A randomized controlled trial. Blood. 223-231.
  • Show author(s) (2018). Cytokine profiling and post-transfusion haemoglobin increment in patients with haematological diseases. Vox Sanguinis. 657-668.
  • Show author(s) (2017). Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients. Vox Sanguinis. 578-585.
  • Show author(s) (2017). Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres. Vox Sanguinis. 9-17.
  • Show author(s) (2017). A prospective observational study on effects of fever on red cell transfusion outcome. Vox Sanguinis. 484-486.
  • Show author(s) (2016). The Simons Genome Diversity Project: 300 genomes from 142 diverse populations. Nature. 201-206.
  • Show author(s) (2016). Survival after ultramassive transfusion: A review of 1360 cases. Transfusion. 558-563.
  • Show author(s) (2016). Making whole blood available in austere medical environments: Donor performance and safety. Transfusion. S166-S172.
  • Show author(s) (2016). Intraoperative transfusion practices in Europe. British Journal of Anaesthesia. 255-261viii.
  • Show author(s) (2016). Immunomodulation induced by stem cell mobilization and harvesting in healthy donors: Increased systemic osteopontin levels after treatment with granulocyte colony-stimulating factor. International Journal of Molecular Sciences.
  • Show author(s) (2016). A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: The Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial. BMJ Open.
  • Show author(s) (2015). The role of recent admixture in forming the contemporary West Eurasian genomic landscape. Current Biology. 2518-2526.
  • Show author(s) (2015). The lost art of whole blood transfusion in austere environments. Current sports medicine reports. 129-134.
  • Show author(s) (2015). Low frequency of anti-D alloimmunization following D+ platelet transfusion: The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study. British Journal of Haematology. 598-603.
  • Show author(s) (2015). Global diversity, population stratification, and selection of human copy-number variation. Science.
  • Show author(s) (2015). Freeze dried plasma and fresh red blood cells for civilian prehospital hemorrhagic shock resuscitation. Journal of Trauma and Acute Care Surgery. S26-S30.
  • Show author(s) (2015). Coagulation function of stored whole blood is preserved for 14 days in austere conditions: A ROTEM feasibility study during a Norwegian antipiracy mission and comparison to equal ratio reconstituted blood. Journal of Trauma and Acute Care Surgery. S31-S38.
  • Show author(s) (2015). A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment. Vox Sanguinis. 343-352.
  • Show author(s) (2014). Whole blood: The future of traumatic hemorrhagic shock resuscitation. Shock. 62-69.
  • Show author(s) (2014). Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: Definitions, current practice, and knowledge gaps. Shock. 3-12.
  • Show author(s) (2014). Refrigerated platelets for the treatment of acute bleeding: A review of the literature and reexamination of current standards. Shock. 51-53.
  • Show author(s) (2014). Prehospital use of plasma: The blood bankers' perspective. Shock. 39-43.
  • Show author(s) (2014). Norwegian red cross - 80 years in service for blood donors. Transfusion and Apheresis Science. 136-138.
  • Show author(s) (2014). Low titer group o whole blood in emergency situations. Shock. 70-75.
  • Show author(s) (2014). Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis. Blood Transfusion. s84-s89.
  • Show author(s) (2014). Emergency whole-blood use in the field: A simplified protocol for collection and transfusion. Shock. 76-83.
  • Show author(s) (2014). Comparison of in vitro responses to fresh whole blood and reconstituted whole blood after collagen stimulation. Blood Transfusion. 50-55.
  • Show author(s) (2014). Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients . Transfusion and Apheresis Science. 97-102.
  • Show author(s) (2014). Ancient human genomes suggest three ancestral populations for present-day Europeans. Nature. 409-413.
  • Show author(s) (2013). Stem cell mobilization and harvesting by leukapheresis alters systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 850-860.
  • Show author(s) (2013). Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia. Transfusion Medicine. 397-406.
  • Show author(s) (2013). Donor performance of combat readiness skills of special forces soldiers are maintained immediately after whole blood donation A study to support the development of a prehospital fresh whole blood transfusion program. Transfusion. 526-530.
  • Show author(s) (2013). Blood doping: The flip side of transfusion and transfusion alternatives. Transfusion and Apheresis Science. 90-94.
  • Show author(s) (2013). Blood Far Forward-a whole blood research and training program for austere environments. Transfusion. 124S-130S.
  • Show author(s) (2013). Anemia treatment of lymphoproliferative malignancies with erypoiesis: An overview of state of the art. Transfusion and Apheresis Science. 277-281.
  • Show author(s) (2012). The peopling of Europe and the cautionary tale of Y chromosome lineage R-M269. Proceedings of the Royal Society of London. Biological Sciences. 884-892.
  • Show author(s) (2012). The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates. Platelets. 299-308.
  • Show author(s) (2012). Symposium on fresh whole blood for severe hemorrhagic shock: From in-hospital to far forward resuscitations. Transfusion and Apheresis Science. 113-117.
  • Show author(s) (2012). Military walking blood bank and the civilian blood service. Transfusion and Apheresis Science. 341-342.
  • Show author(s) (2012). Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST). Transfusion. 1687-1695.
  • Show author(s) (2011). Serum Folate Is Significantly Correlated with Plasma Cysteine Concentrations in Healthy Industry Workers. Annals of Nutrition and Metabolism. 68-73.
  • Show author(s) (2011). Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts? Cytotherapy. 1013-1024.
  • Show author(s) (2011). Evaluation of noninvasive methods for the estimation of haemoglobin content in red blood cell concentrates. Transfusion Medicine. 145-149.
  • Show author(s) (2011). Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 1259-1268.
  • Show author(s) (2011). Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates. Transfusion and Apheresis Science. 75-84.
  • Show author(s) (2011). A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia. European Cytokine Network. 52-62.
  • Show author(s) (2010). Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods. Transfusion. 766-775.
  • Show author(s) (2010). The Mirasol (R) Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution. Blood Transfusion. 186-192.
  • Show author(s) (2010). Self-treatment of an ABO-incompatible blood transfusion. Transfusion and Apheresis Science. 215-216.
  • Show author(s) (2010). Pathogen inactivation of platelet concentrates. Vox Sanguinis. 85-95.
  • Show author(s) (2010). Monitoring and treatment of anti-D in pregnancy. Vox Sanguinis. 177-192.
  • Show author(s) (2010). Minor diurnal and activity-induced variations in daytime peripheral blood platelet counts do not have any major impact on platelet yield by platelet apheresis. Transfusion and Apheresis Science. 33-36.
  • Show author(s) (2010). Effekten av blodgivningsfrekvens på jernstatus. Bioingeniøren. 6-10.
  • Show author(s) (2010). Effect of iron supplementation on iron status during the first week after blood donation. Vox Sanguinis. e249-e256.
  • Show author(s) (2010). Blood donors with hereditary hemochromatosis. Transfusion. 1787-1793.
  • Show author(s) (2010). A pilot study of the possibility and the feasibility of haemoglobin dosing with red blood cells transfusion. Vox Sanguinis. 71-76.
  • Show author(s) (2009). Thrombelastography. Transfusion and Apheresis Science. 119-123.
  • Show author(s) (2009). Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods. Transfusion.
  • Show author(s) (2009). The effect of blood donation frequency on iron status. Transfusion and Apheresis Science. 165-169.
  • Show author(s) (2009). The effect of blood donation frequency on iron status. Transfusion and Apheresis Science. 165-169.
  • Show author(s) (2009). Left ventricular long-axis function in treated haemochromatosis. The International Journal of Cardiac Imaging. 237-247.
  • Show author(s) (2009). Left ventricular diastolic function in patients with treated haemochromatosis. Scandinavian Cardiovascular Journal. 32-38.
  • Show author(s) (2009). Iron status in Norwegian blood donors: comparison of iron status in new blood donors registered in 1993-1997 and in 2005-2006. Vox Sanguinis. 49-55.
  • Show author(s) (2009). Iron status in Norwegian blood donors: comparison of iron status in new blood donors registered in 1993-1997 and in 2005-2006. Vox Sanguinis. 49-55.
  • Show author(s) (2009). Immunization in pregnancy. Tidsskrift for Den norske legeforening. 2016-2018.
  • Show author(s) (2009). Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors. Transfusion. 2359-2365.
  • Show author(s) (2009). Connexins Are Active Participants of Hematopoietic Stem Cell Regulation. Stem Cells and Development. 807-812.
  • Show author(s) (2009). A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood. 1564-1573.
  • Show author(s) (2008). Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro. Platelets. 155-159.
  • Show author(s) (2008). Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro. Platelets. 55-159.
  • Show author(s) (2007). Reduced exercise capacity in genetic haemochromatosis. European Journal of Cardiovascular Prevention & Rehabilitation. 470-475.
  • Show author(s) (2007). In vitro evaluation of platelet concentrates during storage: platelet counts and markers of platelet destruction. Transfusion and Apheresis Science. 261-268.
  • Show author(s) (2007). In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion. 653-665.
  • Show author(s) (2006). Evaluation of a porcine model to study in vivo platelet activation. Thrombosis Research. 341-352.
  • Show author(s) (2005). Large-volume leukapheresis yields more viable CD34+cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+cells. Transfusion. 248-253.
  • Show author(s) (2004). The platelet count accuracy of platelet concentrates obtained by using automated analysis is influenced by instrument bias and activated platelet components. Vox Sanguinis. 196-203.
  • Show author(s) (2004). Guidelines for transfusion in Norway. Transfusion and Apheresis Science. 181-184.
  • Show author(s) (2022). Pure red cell aplasia after hematopoietic stem cell transplantation - experimental therapeutic approaches. Expert Opinion on Investigational Drugs. 881-884.
  • Show author(s) (2017). The blood donor with hemochromatosis: To be or not to be! Transfusion and Apheresis Science. 484-484.
  • Show author(s) (2010). Current debate on pathogen inactivation of platelet concentrates - To use or not to use? Transfusion and Apheresis Science. 411-414.
  • Show author(s) (2009). Does the preoperative iron status predict transfusion requirement of orthopedic patients? Transfusion and Apheresis Science. 213-217.
Reader opinion piece
  • Show author(s) (2010). Platelet transfusion in acute leukemia patients with severe chemotherapy-induced thrombocytopenia: the possible importance of hemoglobin levels and red blood cell transfusions for evaluation of clinical effects of transfusion. Transfusion. 2505-2506.
  • Show author(s) (2010). Inventory Management. Vox Sanguinis. e295-e363.
Short communication
  • Show author(s) (2018). Staff officers as blood suppliers: Effects of repeated donations and autologous reinfusions of untransfused units. Journal of Trauma and Acute Care Surgery. S89-S92.
Masters thesis
  • Show author(s) (2005). The functional quality of INTERCEPT – treated platelets during storage.
Popular scientific article
  • Show author(s) (2021). En ung kvinne med pustevansker og proteinuri. Tidsskrift for Den norske legeforening.
Feature article
  • Show author(s) (2022). Covid-19-rekonvalesensplasma fra norske blodgivere. Tidsskrift for Den norske legeforening. 768-770.
  • Show author(s) (2020). Pasient med alvorlig covid-19 behandlet med rekonvalesensplasma. Tidsskrift for Den norske legeforening. 1-4.
  • Show author(s) (2009). Immunisering i svangerskapet. Tidsskrift for Den norske legeforening. 2016-2018.
Doctoral dissertation
  • Show author(s) (2018). Recent developments in military transfusion practice and their impact on civilian healthcare.
  • Show author(s) (2000). The significance of endogenous serotonin content on storage of human platelet concentrates.
Academic chapter/article/Conference paper
  • Show author(s) (2007). Blood levels of lipids and serotonin as predictors of self harm and violence in acutely admitted psychiatric patients [Poster 17]. 1 pages.
  • Show author(s) (2013). Pathogen reduction technology treatment of tacsi platelets in plasma. Vox Sanguinis. 136-137.
  • Show author(s) (2010). Why is potentional blood donors deferred from donation? Haematologica. 738-738.
  • Show author(s) (2010). Evaluation of the effect of an enhanced leukocyte-reduction filter (RCM3) on in vitro and in vivo red cell viability after 35 and 42 days of storage. Vox Sanguinis. 219-219.
  • Show author(s) (2010). Evaluation of the effect of a combined prion and leukocyte-reduction filter (PRF2) on in vivo and in vitro red cell storage viability. Vox Sanguinis. 218-219.
  • Show author(s) (2010). Erythrocytapheresis is not superior to whole blood phlebotomy in patients with hereditary hemochromatosis. Haematologica. 706-707.
  • Show author(s) (2008). The effect of blood donation on haemoglobin concentration.
  • Show author(s) (2007). Iron status in blood donors.
Academic literature review
  • Show author(s) (2020). Re-introducing whole blood for transfusion: considerations for blood providers. Vox Sanguinis. 1-8.
  • Show author(s) (2019). The use of thromboelastography (TEG) in massively bleeding patients at Haukeland University Hospital 2008-15. Transfusion and Apheresis Science. 1-5.
  • Show author(s) (2017). Microcirculation and red cell transfusion in patients with sepsis. Transfusion and Apheresis Science. 900-905.
  • Show author(s) (2017). Hemochromatosis and blood donation. Transfusion and Apheresis Science. 485-489.
  • Show author(s) (2017). Efficacy of humanized Mesenchymal stem cell cultures for bone tissue engineering: a systematic review with a focus on platelet derivatives. Tissue Engineering Part B: Reviews. 552-569.
  • Show author(s) (2016). Whole blood for hemostatic resuscitation of major bleeding. Transfusion. S190-S202.
  • Show author(s) (2016). Implementing a patient blood management program in Norway: Where to start? Transfusion and Apheresis Science. 422-427.
  • Show author(s) (2014). Storage and handling of blood components - perspectives . Transfusion and Apheresis Science. 103-106.
  • Show author(s) (2014). Effects of the Sangvia blood collection system on patients undergoing elective hip surgery. Transfusion and Apheresis Science. 91-96.
  • Show author(s) (2011). Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia. Blood reviews. 113-122.
  • Show author(s) (2010). Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience. Journal of Biomedicine and Biotechnology. 15 pages.
  • Show author(s) (2009). Granulocyttransfusjon. Tidsskrift for Den norske legeforening. 416-419.
  • Show author(s) (2009). Connexins are active participants of hematopoietic stem cell regulation. Stem Cells and Development. 807-812.
  • Show author(s) (2009). Autoimmun hemolytisk anemi. Tidsskrift for Den norske legeforening. 2226-2231.
Article in business/trade/industry journal
  • Show author(s) (2020). How do I implement a whole blood–based blood preparedness program in a small rural hospital? Transfusion. 1-8.
  • Show author(s) (2009). Jernstatus hos blodgivere i Norge : sammenligning av jernstatus hos nye blodgivere registrert i 1993-1997 og i 2005-2006. Bioingeniøren. 6-11.

More information in national current research information system (CRIStin)